mivocabtagene autoleucel

News

Kyverna has data with miv-cel in stiff person syndrome that shows durable efficacy and safety and seems to sidestep issues flagged with other CAR-Ts.

News

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik, setting up a market tussle with Novo's recently launched Awiqli.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.